C71T
CANCELLED SECTION 71
24/04/2026
Voltar para busca
Dado oficial do USPTO
FORSANTE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
FORSANTE
ST13
US500000079250822Classe
35, 38, 42, 44
Pedido
79250822
Registro
5876711
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
24
Atualização mais recente
19/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 38, 42, 44
Data de depósito
03/10/2018
Data de registro
08/10/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/04/2026
Última transação
19/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
FI
Examinador
EISNACH, MICHAEL PATRICK
Unidade examinadora
L40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Valuecode Oy
Representantes
Robert D. Fish Fish IP Law LLP
Classificação técnica
Classes Nice
Classe 35Classe 38Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Compilation of statistics; compilation of statistics for medical purposes; systemization of information into computer databases
Classe 38
Electronic data transmission; transmission of digital files; transmission of messages; transmission of database information via telecommunications networks
Classe 42
Medical research services; scientific investigations for medical purposes; consultancy pertaining to pharmacology; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the field of diabetes; scientific research for medical purposes in the field of nephrology; scientific research for medical purposes in the field of arthritis; scientific research for medical purposes in the field of pulmonary diseases; scientific research for medical purposes in the field of cardiovascular diseases; computer programming in the medical field; computer programming of computer games in the field of health care; programming educational software featuring instruction in the medical field; providing online non-downloadable computer software for use in the health care fieldsoftware for managingstoringanalyzingmaintainingprocessingstructuringreviewingbuildingeditingdistributingcommunicatingorganizingsharingreferencingmonitoring and integrating health care information; data mining; electronic data storage; computer consulting in the field of information technology systems for managing patient clinical information; software as a service (SAAS) serviceshosting software for use by others for use in medical researchhealth care information management and pharmaceutical advice; platform as a service (PAAS) featuring computer software platforms for use in medical researchhealth care information management and pharmaceutical advice
Classe 44
Pharmaceutical advice; dispensing of pharmaceuticals; medical counseling; medical screening; medical screening information services featuring reminder alerts regarding dispensation of pharmaceuticals; medical advisory services; medical consultations; medical testing for diagnostic or treatment purposes; medical services; medical servicesproviding medical services and consultation via the internet through the use of personal computerssmartphonestabletsmobile and wireless devicesother telecommunication devices; medical services in the field of diabetes; medical services in the field of nephrology; medical services in the field of oncology; medical services in the field of arthritis; medical services in the field of pulmonary diseases; medical services in the field of cardiovascular diseases; conducting medical examinations for diagnostic purposes; medical analysis services relating to the treatment of patients; performing diagnosis of diseases; managed health care services
Publicações
Histórico de despachos e eventos da marca no USPTO.
24 publicações encontradas
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/10/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
21/02/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/02/2020
FIMP
FINAL DISPOSITION PROCESSED
03/02/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/01/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
08/10/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/07/2019
PUBO
PUBLISHED FOR OPPOSITION
23/07/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/07/2019
ALIE
ASSIGNED TO LIE
14/06/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/06/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/05/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
31/05/2019
RFNT
REFUSAL PROCESSED BY IB
09/03/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
21/02/2019
RFRR
REFUSAL PROCESSED BY MPU
21/02/2019
MAFR
APPLICATION FILING RECEIPT MAILED
12/02/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/02/2019
CNRT
NON-FINAL ACTION WRITTEN
08/02/2019
DOCK
ASSIGNED TO EXAMINER
06/02/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/02/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
31/01/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace FORSANTE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.